What's breaking now, across thousands of outlets.
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
Key PointsOracle sent Project Jupiter’s developer a force majeure notice that could let it defer payments if the New Mexico data center misses its 2028 target.
Inox Clean Energy is set to launch a ₹10,000 crore IPO by filing a draft red herring prospectus, potentially marking the largest IPO in the Indian private renewable energy sector to date.
Nigerian pension funds have committed N241bn to infrastructure development, with the first tranche expected to be deployed by Q2 2027, PenCom has disclosed Read More…
